Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dulaglutide for hyperglycemia associated with R-CHOP therapy in malignant lymphoma
jRCT1031200022Recruiting
- Start
- Apr 2020
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of dulaglutide in type 2 diabetes mellitus (T2DM) and lymphoma. Started Apr 2020; status: recruiting.
02
Drugs
dulaglutide
03
Conditions
type 2 diabetes mellitus (T2DM)lymphoma
Beyond the preview
Go deeper on jRCT1031200022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031200022.